Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ORPN

Bioblast Pharma (ORPN) Stock Price, News & Analysis

Bioblast Pharma logo

About Bioblast Pharma Stock (NASDAQ:ORPN)

Advanced Chart

Key Stats

Today's Range
$1.32
$1.39
50-Day Range
$11.50
$28.49
52-Week Range
$6.16
$30.00
Volume
214,110 shs
Average Volume
N/A
Market Capitalization
$567 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ORPN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioblast Pharma and its competitors with MarketBeat's FREE daily newsletter.

ORPN Stock News Headlines

Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...
See More Headlines

ORPN Stock Analysis - Frequently Asked Questions

Shares of Bioblast Pharma reverse split on the morning of Wednesday, March 6th 2019.The 1-8 reverse split was announced on Wednesday, March 6th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, March 5th 2019. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioblast Pharma investors own include Inovio Pharmaceuticals (INO), Synergy Pharmaceuticals (SGYP), SELLAS Life Sciences Group (SLS), Immunomedics (IMMU), Athersys (ATHX), ContraFect (CFRX) and Corbus Pharmaceuticals (CRBP).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ORPN
CIK
1596812
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.56 per share
Price / Book
0.18

Miscellaneous

Outstanding Shares
420,000
Free Float
N/A
Market Cap
$567 thousand
Optionable
Not Optionable
Beta
1.41
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:ORPN) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners